Crux Biomedical Raises Series B

Crux Biomedical Inc., a Menlo Park, Calif.-based developer of a device for treating and preventing pulmonary embolisms, has raised around $8 million in Series B funding, according to VentureWire. Return backers include Alloy Ventures and Thomas Fogarty. www.cruxbiomedical.com